Organization
Pfizer Japan Inc
1 abstract
Abstract
BIOMARKER CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB WITH METHOTREXATE OR GLUCOCORTICOIDS VS TOFACITINIB MONOTHERAPYOrg: Pfizer Inc., Collegeville, PA, United States, Pfizer Japan Inc,